A new trading day began on Monday, with Geron Corp (NASDAQ: GERN) stock price up 6.25% from the previous day of trading, before settling in for the closing price of $1.28. GERN’s price has ranged from $1.09 to $4.84 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 5.60%. Meanwhile, its annual earnings per share averaged 64.98%. With a float of $604.93 million, this company’s outstanding shares have now reached $637.85 million.
Let’s determine the extent of company efficiency that accounts for 229 employees. In terms of profitability, gross margin is 68.93%, operating margin of -47.08%, and the pretax margin is -53.52%.
Geron Corp (GERN) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Geron Corp is 5.19%, while institutional ownership is 76.80%. The most recent insider transaction that took place on May 09 ’25, was worth 15,667. In this transaction Director of this company bought 13,300 shares at a rate of $1.18, taking the stock ownership to the 13,300 shares. Before that another transaction happened on Feb 27 ’25, when Company’s EVP, Chief Legal Officer bought 15,000 for $1.61, making the entire transaction worth $24,150. This insider now owns 26,682 shares in total.
Geron Corp (GERN) Recent Fiscal highlights
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.04 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 64.98% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Here are Geron Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.79. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.13, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.01 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Looking closely at Geron Corp (NASDAQ: GERN), its last 5-days average volume was 15.53 million, which is a jump from its year-to-date volume of 12.8 million. As of the previous 9 days, the stock’s Stochastic %D was 65.69%.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 33.75%, which indicates a significant decrease from 79.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0814 in the past 14 days, which was lower than the 0.1017 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3873, while its 200-day Moving Average is $2.3180. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.4100. Second resistance stands at $1.4600. The third major resistance level sits at $1.5100. If the price goes on to break the first support level at $1.3100, it is likely to go to the next support level at $1.2600. Now, if the price goes above the second support level, the third support stands at $1.2100.
Geron Corp (NASDAQ: GERN) Key Stats
With a market capitalization of 867.70 million, the company has a total of 638,017K Shares Outstanding. Currently, annual sales are 76,990 K while annual income is -174,570 K. The company’s previous quarter sales were 39,600 K while its latest quarter income was -19,840 K.
